INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
eCOA Standards And KPIs To Include In Your Next RFI
Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.
-
Clinical Trial Payments At Scale: Volume And Control
Find an operational explanation of what payment scale actually means in clinical trials, why small-study approaches break down, and how volume reshapes compliance, reporting, and automation decisions.
-
Global e-Consent Matrix
Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.
-
The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up9/3/2025
Transactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.
-
How Do Site Payments Impact Clinical Trial Sustainability?4/16/2025
Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
-
On The GO: Inside The World Of Clinical Trial Travel Coordination (USA)11/19/2024
Clinical trial Concierge Coordinators provide personalized support, addressing travel, logistics, and unique challenges for participants and caregivers, ensuring engagement, and trial success.
-
Why Early CRO Choice Is Critical To Accelerating Delivery Of Your Clinical Program2/9/2026
Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.
-
How Sponsors Can Leverage New Technologies To Lower Trial Costs1/6/2025
This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.
-
PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.